Mouse model of post-surgical breakdown of the blood-retinal barrier

Current Eye Research

Volumn 28, Issue 6, 2004, Pages 421-426

  Liu, Hansheng ^a   Demetriades, Anna Maria ^a   Xiao, Wei Hong ^a   Campochiaro, Peter A ^a   Vinores, Stanley A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Blood retinal barrier; Macular edema; Mouse model; Ocular surgery; Vasopermeability factors

Indexed keywords

ALBUMIN; MANNITOL; PROTEIN; TRACER; TRITIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPIRATION; BLOOD RETINA BARRIER; CATARACT EXTRACTION; CONTROLLED STUDY; CORNEA LIMBUS; DISEASE MODEL; IMMUNOHISTOCHEMISTRY; INFUSION; LENS; MOUSE; NEEDLE; NONHUMAN; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN TRANSPORT; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RETINA; RETINA BLOOD VESSEL; RETINA MACULA EDEMA;

ANIMALS; APHAKIA, POSTCATARACT; BLOOD-RETINAL BARRIER; DISEASE MODELS, ANIMAL; LENS, CRYSTALLINE; MACULAR EDEMA, CYSTOID; MALE; MICE; MICE, INBRED C57BL; POSTOPERATIVE COMPLICATIONS; RETINA; RETINAL VESSELS; SERUM ALBUMIN;

EID: 4143058321     PISSN: 02713683     EISSN: None     Source Type: Journal    
DOI: 10.1080/02713680490503769     Document Type: Article

References (34)

1. Irvine SR. A newly defined vitreous syndrome following cataract surgery. Am J Ophthalmol. 1953;36:599-619.
2. Gass JD, Norton EW. Cystoid macular edema and papilledema following cataract extraction. Arch Ophthalmol. 1966;76:646-661.
3. Miyake K, Mibu H, Horiguchi M, Shirasawa E. Inflammatory mediators in postoperative aphakic and pseudophakic baboon eyes. Arch Ophthalmol. 1990;108:1764-1767.
4. Kraff MC, Sanders DR, Jampol LM, Lieberman HL. Effect of ultraviolet-filtering intraocular lens on cystoid macular edema. Ophthalmol. 1985;92:366-369.
5. Tso MOM, Shih CY. Disruption of blood-retinal barrier in ocular hypotony: Preliminary report. Exp Eye Res. 1976;23:209-216.
6. Predescu D, Ihida K, Predescu S, Palade GE. The vascular distribution of the platelet-activating factor receptor. Eur J Cell Biol. 1996;69:86-98.
7. de Lima WT, Kwasniewski FH, Sirois P, Jancar S. Studies on the mechanism of PAF-induced vasopermeability in rat lungs. Prostaglandins Leukot Essen Fatty Acids. 1995;52:245-249.
8. Rhee CK, Park YS, Long SA, Jung TT, Davamony D. Effects of platelet activating factor on vascular permeability of the middle ear mucosa. Ann Otol Rhinol Laryngol. 1997;106:604-607.
9. Fujii E, Irie K, Uchida Y, Ohba K, Muraki T. Role of eicosanoids but not nitric oxide in the platelet activating factor-induced increase in vascular permeability in mouse skin. Eur J Pharmacol. 1995;273:267-272.
10. Miyake K. Indomethacin in the treatment of postoperative cystoid macular edema. Surv Ophthalmol. 1984;28:554-568.
11. Bazan NG. Metabolism of arachidonic acid in the retina and retinal pigment epithelium: Biological effects of oxygenated metabolites of arachidonic acid. Prog Clin Biol Res. 1989;312:15-37.
12. Mishima H, Masuda KKM. The putative role of prostaglandins in cystoid macular edema, Alan R. Liss, Inc., 1989, pp. 251-264.
13. Vinores SA, Sen H, Campochiaro PA. An adenosine agonist and prostaglandin E1 cause breakdown of blood-retinal barrier by opening tight junctions between vascular endothelial cells. Invest Ophthalmol Vis Sci. 1992;33:1870-1878.
14. Neufeld AH, Sears ML. The site of action of prostaglandin E2 on the disruption of the blood-aqueous barrier in the rabbit eye. Exp Eye Res. 1973;17:445-448.
15. Vegge T, Neufeld AH, Sears ML. Morphology of the breakdown of the blood-aqueous barrier in the ciliary processes of the rabbit eye after prostaglandin E2. Invest Ophthalmol Vis Sci. 1975;14:33-36.
16. Derevjanik NL, Vinores SA, Xiao W-H, Mori K, Turon T, Hudish T, Dong S, Campochiaro PA. Quantitative assessment of the integrity of the blood-retinal barrier in mice. Invest Ophthalmol Vis Sci. 2002;43:2462-2467.
17. Miyake K. Prophylaxis of aphakic cystoid macular edema using topical indomethacin. J Am Intraocul Implant Soc. 1978;4:174-179.
18. Heier JS, Topping TM, Baumann W, Dirks MS, Chern S. Ketorolac versus prednisolone versus combination therapy in the treatment of acute pseudophakic cytoid macular edema. Ophthalmology. 2000;107:2034-2039.
19. Thach AB, Dugel PU, Flindall RJ, Sipperley JO, Sneed SR. A comparison of retrobulbar versus sub-tenon's corticosteroid therapy for cystoid macular edema refractory to topical medications. Ophthalmology. 1997;104:2003-2008.
20. Antcliff RJ, Spalton DJ, Stanford MR, Graham EM, Ffytche TJ, Marshall J. Intravitreal triamcinolone for uveitic cystoid macular edema: An optical coherence tomography study. Ophthalmology. 2001;108:765-772.
21. Pendergast SD, Margherio RR, Williams GA, Cox MS. Vitrectomy for chronic pseudophakic cystoid macular edema. Am J Ophthalmol. 1999;128:317-323.
22. Tso MOM, Shih CY. Experimental macular edema after lens extraction. Invest Ophthalmol Vis Sci. 1977;16:381-392.
23. Vinores SA, Gadegbeku C, Campochiaro PA, Green WR. Immunohistochemical localization of blood-retinal barrier breakdown in human diabetics. Am J Pathol. 1989;134:231-235.
24. Vinores SA, Campochiaro PA, Lee A, McGehee R, Gadegbeku C, Green WR. Localization of blood-retinal barrier breakdown in human pathologic specimens by immunohistochemical staining for albumin. Lab Invest. 1990;62:742-750.
25. Quentel G, Zerah I, Coscas G. Vitreous fluorophotometry studies in aphakia. Graefes Arch Clin Exp Ophtalmol. 1985;222:248-249.
26. Ferguson VM, Spalton DJ. Continued breakdown of the blood aqueous barrier following catract surgery. Br J Ophthalmol. 1992;76:453-456.
27. Meredith TA, Kenyon KR, Singerman LJ, Fine SL. Perifoveal capillary leakage and macular edema after intracapsular cataract extraction. Br J Ophthalmol. 1976;60:765-769.
28. Wright PL, Wilkinson CP, Balyeat HD, Popham J, Reinke M. Angiographic cystoid macular edema after posterior chamber IOL implantation. Arch Ophthalmol. 1988;106:740.
29. Terasaki H, Miyake K, Miyake Y. Reduced oscillatory potentials of the full-field electroretinogram of eyes with aphakic or pseudophakic cystoid macular edema. Am J Ophthalmol. 2003;135:477-482.
30. Tobe T, Ortega S, Luna JD, Ozaki H, Okamoto N, Derevjanik NL, Vinores SA, Basilico C, Campochiaro PA. Targeted disruption of the FGF2 gene does not prevent choroidal neovascularization in a murine model. Am J Pathol. 1998;153:1641-1646.
31. Ozaki H, Okamoto N, Ortega S, Chang M, Ozaki K, Sadda S, Vinores MA, Derevjanik N, Zack DJ, Basilico C, Campochiaro PA. Basic fibroblast growth factor is neither necessary nor sufficient for the development of retinal neovascularization. Am J Pathol. 1998;153:757-765.
32. Yamada E, Tobe T, Yamada H, Okamoto N, Zack DJ, Werb Z, Soloway PD, Campochiaro PA. TIMP-1 promotes VEGF-induced neovascularization in the retina. Histol Histopath. 2001;16:87-97.
33. Ando A, Yang A, Mori K, Yamada H, Yamada E, Takahashi K, Saikia J, Kim M, Melia M, Fishman M, Huang P, Campochiaro PA. Nitric oxide is proangiogenic in retina and choroid. J Cell Physiol. 2001;191:116-124.
34. Hackett SF, Wiegand SJ, Yancopoulos G, Campochiaro P. Angiopoietin-2 plays an important role in retinal angiogenesis. J Cell Physiol. 2002;192:182-187.